Soya oil 20% infusion 500ml bags
Requires a prescription from a doctor or prescriber
Derived from soybeans, soybean oil is a common vegetable oil and a source of polyunsaturated and saturated fatty acids.
Safety information for pregnancy and breastfeeding
Pregnancy
Always consult your doctor or midwife before taking any medicine during pregnancy or while breastfeeding. Source: DrugBank (CC BY-NC 4.0).
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Part of the Lipofundin brand family (generic: Soya oil)
MHRA licensed products
View all licensed products for Soya oil on the MHRA register
Intralipid 20% infusion 500ml bags
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 8 · Randomised trials: 2 · 1968–2025
Showing the 50 most relevant studies, sorted by most relevant.
F. Arrutia, E. Binner, P. Williams, et al.
Trends in Food Science & Technology, 2020
J. Pirker, Aline Mosnier, Florian Kraxner, et al.
Global Environmental Change, 2016
Peipei Zhang, Hongyang Du, Jiao Wang, et al.
Plant Biotechnology Journal, 2019
- Isoflavones
- Mosaic Viruses
- Glycine max
Yupeng Cai, Li Chen, Xiujie Liu, et al.
Plant Biotechnology Journal, 2017
- Gene Editing
- Plant Proteins
- Glycine max
Y Zhang, Marc A. Dubé, David D. McLean, et al.
Bioresource Technology, 2003
- Waste Products
- Models, Economic
- Biotechnology
Patrick Biller, Andrew B. Ross
Bioresource Technology, 2010
- Cyanobacteria
- Biotechnology
- Carbohydrates
The Lancet, 1968
- Diet Therapy
- Fats, Unsaturated
- Blood Pressure
Annapurna Kumari, Paramita Mahapatra, Vijay Kumar Garlapati, et al.
Biotechnology for Biofuels, 2009
R. H. V. Corley
Environmental Science & Policy, 2008
Alfred A. Christy, Sumaporn Kasemsumran, Yiping Du, et al.
Analytical Sciences, 2004
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Fatty acids serve as an important substrate for energy production.
Food interactions
None known
Human targets
1 target
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
Protein binding
Volume of distribution
Metabolism
Elimination
Clearance
[L854]…
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
[L51013]
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 87 interactions
Worsensing conditions of the patients can be seen including hematological effects, declined hepatic function and central nervous system manifestations. Hypertriglyceridema may occur. Preterm and small-for-gestational-age infants have poor clearance of intravenous lipid emulsion and increased free fatty acid plasma levels following lipid emulsion infusion, leading to accumulation in lungs.
It is advised not to exceed 0.75 mL/kg/hour.
How the body processes this drug — absorption, distribution, metabolism, and elimination
[L854]
Proteins and enzymes this drug interacts with in the body
Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids.
Functions as a transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Soybean oil
Matched from: Soya oil
Additional database identifiers
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q4206658), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.